Balchem Corp
BCPC
Rangering i aksjer
#3247
Balchem Corporation develops, manufactures, and distributes specialty... Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Aksjekurs
$171.40
Sist synkronisert: 2026-10-20
Markedsverdi
$5.46B
Endring (1 dag)
0.57%
Endring (1 år)
9.25%
Land
US
Handel Balchem Corp (BCPC)
Kategori
Basic Materials
P/E-forhold for Balchem Corp (BCPC)
P/E-forhold per October 2026 TTM: 33.29
Ifølge Balchem Corp sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 33.29. Ved slutten av 2023 hadde selskapet en P/E på 44.00.
P/E-forholdshistorikk for Balchem Corp fra 2000 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 33.29 | -18.84% |
| 2024 | 41.02 | -6.77% |
| 2023 | 44.00 | 18.58% |
| 2022 | 37.11 | -34.34% |
| 2021 | 56.52 | 29.00% |
| 2020 | 43.81 | 6.87% |
| 2019 | 40.99 | 27.45% |
| 2018 | 32.16 | 12.26% |
| 2017 | 28.65 | -39.82% |
| 2016 | 47.62 | 50.11% |
| 2015 | 31.72 | -18.48% |
| 2014 | 38.91 | 0.41% |
| 2013 | 38.75 | 44.40% |
| 2012 | 26.84 | -10.19% |
| 2011 | 29.88 | 5.18% |
| 2010 | 28.41 | 17.98% |
| 2009 | 24.08 | 2.48% |
| 2008 | 23.50 | -4.45% |
| 2007 | 24.59 | 0.59% |
| 2006 | 24.45 | 16.30% |
| 2005 | 21.02 | -3.15% |
| 2004 | 21.71 | 11.49% |
| 2003 | 19.47 | 25.00% |
| 2002 | 15.58 | -19.80% |
| 2001 | 19.42 | 17.14% |
| 2000 | 16.58 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 31.66 | -4.89% |
GB
|
|
| - | - |
FR
|
|
| 29.64 | -10.98% |
US
|
|
| 38.37 | 15.26% |
US
|
|
| -1.41K | -4,324.29% |
US
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.